GENETHON

Angela Columbano, Ph.D., Head Business Development and Partnership 

Oct. 13 | 9:30am | Oxford Biomedica Ballroom 

Evry, France 

(Private) 

In-person Presentation 

Genethon has been pioneering gene therapy for 30 years. Genethon’s teams have originated multiple gene therapy successes that are now bringing tremendous benefits for patients. Dedicated to tackling rare diseases, Genethon has accumulated world-class expertise in the identification of gene targets, product design, and manufacturing as well as preclinical and clinical development of gene therapies. With 200+ scientists and professionals, Genethon is pursuing its mission to bring life-changing therapies to patients suffering from rare genetic diseases and eradicate these pathologies. Genethon is a not-for-profit organization, created in 1990 by the French Muscular Dystrophy Association (AFM-Telethon) 

www.genethon.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions